⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVS News
Corvus Pharmaceuticals, Inc.
Form 8-K
sec.gov
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
CRVS
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
globenewswire.com
CRVS
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
CRVS
$1.75+ Bn Animal Wound Care (Surgical (Sutures & Staplers), Advanced (Foam, Hydrocolloid, Hydrogel), Traditional (Tapes, Bandages)) Markets - Global Forecast to 2030
globenewswire.com
MMM
MDT
NEO
ZTS
CRVS
NMDP Appoints Ginna Laport, MD, to New Senior Physician Leadership Role
globenewswire.com
CRVS
TEMT
GNSS
CARG
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME